-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
LogicBio Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q3 2018 to Q3 2022.
- LogicBio Therapeutics, Inc. Interest Expense for the quarter ending September 30, 2022 was $176K, a 34.8% decline year-over-year.
- LogicBio Therapeutics, Inc. Interest Expense for the twelve months ending September 30, 2022 was $837K, a 24% decline year-over-year.
- LogicBio Therapeutics, Inc. annual Interest Expense for 2021 was $1.07M, a 2.55% decline from 2020.
- LogicBio Therapeutics, Inc. annual Interest Expense for 2020 was $1.1M, a 101% increase from 2019.
- LogicBio Therapeutics, Inc. annual Interest Expense for 2019 was $546K, a 27200% increase from 2018.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)